Loading...
NPI 1649262007 · Beaumont, TX · Family Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Shama Quraishi is a family medicine physician provider located in Beaumont, Texas. This profile covers 13 Medicare and 17 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Shama Quraishi |
| Address | 2342 Dowlen Rd Ste 102 |
| City | Beaumont |
| State | TX |
| ZIP | 77706 |
| Taxonomy | Family Medicine Physician |
| NPI Enumerated | August 22, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $389.7K |
| Medicare | $54.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 400 | $50 | $20.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 180 | $90 | $15.6K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 70 | $130 | $8.3K |
| 99495 | The provider manages the care of a patient during the transition to home care after discharge from a healthcare facility. The patient’s care requires at least moderate medical decision making,… | 20 | $140 | $2.1K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 30 | $70 | $2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $90 | $1.4K |
| 90756 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no antibiotics, and is administered as a 0.5 mL injection into… | 40 | $30 | $1.4K |
| G0008 | Administration of influenza virus vaccine | 40 | $30 | $1.2K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 20 | $40 | $700 |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 30 | $20 | $480 |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 99214 | 11,634 | 32,500 | 110 | $80 | $17.6K |
| G0439 | 3,076 | 7,110 | 60 | $120 | $10.6K |
| 99213 | 2,434 | 29,790 | 70 | $60 | $8.4K |
| 99204 | 13,096 | 16,380 | 30 | $110 | $5.6K |
| 99203 | 5,731 | 10,820 | 30 | $70 | $3.4K |
| 99495 | 463 | 750 | 20 | $140 | $3.1K |
| G0008 | 4,233 | 7,860 | 50 | $30 | $2.3K |
| 87426 | 928 | 1,870 | 20 | $30 | $1.3K |
| 90756 | 59 | 210 | 30 | $30 | $1.3K |
| 80305 | 202 | 350 | 40 | $10 | $1.1K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 6,720 | $30 | $167.9K |
| 99091 | The provider interprets medical information, such as ECG recordings, blood pressure records, and home glucose monitoring results, received in digital form from a patient or his caregiver requiring at… | 530 | $170 | $90.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,220 | $40 | $84.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 320 | $60 | $18.1K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 160 | $50 | $8.1K |
| 99396 | The provider performs an established well–patient visit for a patient who is between the ages of 40 and 64. | 120 | $60 | $6.7K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 60 | $40 | $2.8K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 250 | $10 | $2.5K |
| 90756 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no antibiotics, and is administered as a 0.5 mL injection into… | 190 | $10 | $2.5K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 100 | $10 | $1.3K |
Showing 1–10 of 17
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
17 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,037 | 6,040 | 710 | $40 | $232.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,416 | 5,810 | 540 | $50 | $155.5K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 1,030 | 1,350 | 320 | $30 | $101.2K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 495 | 850 | 260 | $40 | $77.5K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 596 | 1,860 | 130 | $70 | $65.4K |
| 99091 | The provider interprets medical information, such as ECG recordings, blood pressure records, and home glucose monitoring results, received in digital form from a patient or his caregiver requiring at… | 51 | 190 | 250 | $110 | $60.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 1,451 | 1,520 | 100 | $80 | $50.1K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 1,431 | 1,850 | 510 | $10 | $48.3K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 785 | 1,410 | 200 | $10 | $14.2K |
| 99396 | The provider performs an established well–patient visit for a patient who is between the ages of 40 and 64. | 39 | 150 | 40 | $70 | $10.2K |
Showing 1–10 of 17
Other providers in the same ZIP code as Shama Quraishi, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Raul Isern | TX | Child & Adolescent Psychiatry Physician | $35.7K | $1.4M |
| Reeti Joshi | TX | Rheumatology Physician | $900.9K | $0 |
| Peter Morrell | TX | Dermatology Physician | $616K | $0 |
| Joseph Oommen | TX | Neurology Physician | $365.6K | $0 |
| Jay Proctor | TX | Family Medicine Physician | $310.2K | $0 |
| Kevin Correia | TX | Clinical Psychologist | $169.5K | $0 |
| Wagdy Rizk | TX | Adult Reconstructive Orthopaedic Surgery Physician | $141.9K | $0 |
| John Miller | TX | Diagnostic Radiology Physician | $141K | $0 |
| Burnet Clarke | TX | Orthopaedic Surgery Physician | $130.9K | $0 |
| Gregory Diaz | TX | Diagnostic Radiology Physician | $125.4K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.